STOCKHOLM, Oct. 6, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab-irmb subcutaneous injection (U.S. brand name: Leqembi Iqlik) is now available in the U.S. as a maintenance dosing regimen for the treatment of Alzheimer's...
Hence then, the article about leqembi iqlik lecanemab irmb maintenance treatment launched in the u s was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S. )
Also on site :
- Philippines volcano erupts, blanketing ash across the sky
- Spain demands Israel release arrested Gaza flotilla crew member
- Ukrainian MP calls on Zelensky to fire Umerov over Mindich tapes